Zobrazeno 1 - 10
of 89
pro vyhledávání: '"Andreas O, Doesch"'
Autor:
Rasmus Rivinius, Matthias Helmschrott, Ann‐Kathrin Rahm, Fabrice F. Darche, Dierk Thomas, Tom Bruckner, Andreas O. Doesch, Philipp Ehlermann, Hugo A. Katus, Edgar Zitron
Publikováno v:
ESC Heart Failure, Vol 7, Iss 5, Pp 2082-2092 (2020)
Abstract Aims Amiodarone and digitalis are frequently used drugs in patients with heart failure. Both have separately been linked to reduced post‐transplant survival, but their combined impact on mortality after HTX remains uncertain. This study in
Externí odkaz:
https://doaj.org/article/a297b1b3e3dc4e6bbdc12b4d61d785b2
Autor:
Rasmus Rivinius, Matthias Helmschrott, Arjang Ruhparwar, Bastian Schmack, Fabrice F. Darche, Dierk Thomas, Tom Bruckner, Andreas O. Doesch, Hugo A. Katus, Philipp Ehlermann
Publikováno v:
ESC Heart Failure, Vol 7, Iss 1, Pp 177-188 (2020)
Abstract Aims Severely elevated pre‐transplant pulmonary vascular resistance (PVR) has been linked to adverse effects after heart transplantation (HTX). The impact of a moderately increased PVR before HTX on post‐transplant outcomes remains uncer
Externí odkaz:
https://doaj.org/article/4c5f48484af14dfc967db3113f9da696
Autor:
Karsten M. Heil, Matthias Helmschrott, Fabrice F. Darche, Tom Bruckner, Philipp Ehlermann, Michael M. Kreusser, Andreas O. Doesch, Wiebke Sommer, Gregor Warnecke, Norbert Frey, Rasmus Rivinius
Publikováno v:
Life, Vol 11, Iss 12, p 1344 (2021)
Long-term survival after heart transplantation (HTX) is impacted by adverse effects of immunosuppressive pharmacotherapy, and post-transplant lung cancer is a common occurrence. This study aimed to examine the risk factors, treatment, and prognosis o
Externí odkaz:
https://doaj.org/article/700110ce490a4443bca1a8c6d51a9169
Autor:
Bastian Schmack, Philipp Seppelt, Alexander Weymann, Christina Alt, Mina Farag, Rawa Arif, Andreas O. Doesch, Philip W. Raake, Klaus Kallenbach, Ashham Mansur, Aron-Frederik Popov, Matthias Karck, Arjang Ruhparwar
Publikováno v:
PeerJ, Vol 5, p e3813 (2017)
Objective Extracorporeal life support (ECLS) is a life-saving procedure used in the treatment of severe cardiogenic shock. Within this retrospective single centre study, we examined our experience in this critically ill patient cohort to assess outco
Externí odkaz:
https://doaj.org/article/8489452eb815461da8a1933364726eb0
Autor:
Fabrice F Darche, Matthias Helmschrott, Thomas Bruckner, Ann-Kathrin Rahm, Andreas O. Doesch, Rasmus Rivinius, Philipp Ehlermann, Hugo A. Katus, Edgar Zitron, Dierk Thomas
Publikováno v:
ESC Heart Failure, Vol 7, Iss 5, Pp 2082-2092 (2020)
Aims Amiodarone and digitalis are frequently used drugs in patients with heart failure. Both have separately been linked to reduced post‐transplant survival, but their combined impact on mortality after HTX remains uncertain. This study investigate
Autor:
Bastian Schmack, Thomas Bruckner, Fabrice F Darche, Hugo A. Katus, Andreas O. Doesch, Rasmus Rivinius, Matthias Helmschrott, Philipp Ehlermann, Arjang Ruhparwar, Dierk Thomas
Publikováno v:
ESC Heart Failure
ESC Heart Failure, Vol 7, Iss 1, Pp 177-188 (2020)
ESC Heart Failure, Vol 7, Iss 1, Pp 177-188 (2020)
Aims Severely elevated pre‐transplant pulmonary vascular resistance (PVR) has been linked to adverse effects after heart transplantation (HTX). The impact of a moderately increased PVR before HTX on post‐transplant outcomes remains uncertain. The
Autor:
Christian Erbel, Grigorios Korosoglou, Pearlyn Ler, Mohammadreza Akhavanpoor, Gabriele Domschke, Fabian Linden, Andreas O Doesch, Sebastian J Buss, Evangelos Giannitsis, Hugo A Katus, Christian A Gleissner
Publikováno v:
PLoS ONE, Vol 10, Iss 11, p e0141693 (2015)
BACKGROUND:CXCL4 is a platelet chemokine released at micromolar concentrations upon platelet activation. CXCL4 has been shown to promote atherogenesis by various mechanisms. However, data on CXCL4 plasma levels in patients with coronary artery diseas
Externí odkaz:
https://doaj.org/article/7fd474c0cd024c3e914dcb2aa521b7e4
Autor:
Christoph Knosalla, Hans B. Lehmkuhl, Jens Garbade, Christian Sieder, Stephan Hirt, Jörg Stypmann, Markus J. Barten, Uwe Schulz, Carola Grinninger, Andreas O. Doesch, Christoph Bara, Martina Porstner
Publikováno v:
American Journal of Transplantation. 19:3006-3017
In the 12-month, open-label MANDELA study, patients were randomized at month 6 after heart transplantation to (i) convert to calcineurin inhibitor (CNI)-free immunosuppression with everolimus (EVR), mycophenolic acid and steroids (CNI-free, n=71), or
Autor:
Stephan W. Hirt, Christoph Bara, Markus J. Barten, Tobias Deuse, Andreas O. Doesch, Ingo Kaczmarek, Uwe Schulz, Jörg Stypmann, Assad Haneya, Hans B. Lehmkuhl
Publikováno v:
Journal of Transplantation, Vol 2013 (2013)
The evidence base relating to the use of everolimus in heart transplantation has expanded considerably in recent years, providing clinically relevant information regarding its use in clinical practice. Unless there are special considerations to take
Externí odkaz:
https://doaj.org/article/1778f3bc7fda49fcbe45dad40ac8c7a6
Autor:
Thomas Bruckner, Ann-Kathrin Rahm, Hugo A. Katus, Matthias Helmschrott, Dierk Thomas, Fabrice F Darche, Philipp Ehlermann, Rasmus Rivinius, Andreas O. Doesch
Publikováno v:
Clinical research in cardiology : official journal of the German Cardiac Society. 111(2)
Background Cardiac graft denervation causes inadequate sinus tachycardia in patients after heart transplantation (HTX) which is associated with reduced survival. This study investigated the 5-year results of heart rate control with ivabradine or meto